Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Due Diligence
Comparison
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Companies

Displaying 1..10 of 41 - per page Next page
Order by
Zambon Group is a privately-held multinational pharmaceutical company that in-licenses pharmaceutical products from the discovery to late stage development or already on the market. More
PALAU PHARMA is a newly created biopharmaceutical company devoted to the discovery and development of small molecules for the treatment of inflammatory and autoimmune conditions. More
BiotechEast is a one-stop, full-service marketing consultancy for those looking to take advantage of the dynamic opportunities in Taiwan's burgeoning life science industry. More
Lipocine develop branded products using its proprietary drug delivery technologies. They provide discovery and delivery support for challenging drugs. They issued 14 patents and corporate partnerships More
Focus is on innovations in pharmaceuticals and chemicals More
LABORATORIOS RUBIÓ specialises in the development, manufacture and marketing of APIs and finished dosage forms of niche products More
Laboratorios Senosiain S.A. de C.V. is Mexican company dedicated to the development, production and comercialisation of quality pharmaceutical products. More
We are a young and dynamic marketing and distribution company for quality generic pharmaceuticals in Europe. More
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
Displaying 1..10 of 41 - per page Next page
Order by

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Cardiovascular del
Vascular del

Browse By

Research Partnership for Due Diligence Execution
Biobusiness 2009
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us